After AKI onset, probiotics have demonstrated efficacy in improving renal function, potentially by lowering creatinine and urea levels and significantly reducing pro-inflammatory cytokines like IL-1β, IL-6, TNF-α, and MCP-1 (27). The gene discussed is CCL2; the disease is acute kidney injury.